PUBLIC COMPANY
save$VRCAVerrica Pharmaceuticals Inc.
$VRCAWest Chester, PA, USupdated 21d ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
- phase3Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
- phase2Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
- phase2A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
- phase2Cantharidin and Occlusion in Verruca Epithelium
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that